Medical/Pharmaceuticals

Brii Biosciences Included in Hong Kong Stock Connect

DURHAM, N.C. and BEIJING, Dec. 6, 2021 /PRNewswire/ -- Brii Biosciences  Limited ("Brii Bio" or the "Company", stock code: 2137.HK), today announced that the Company has been added to the Hong Kong Stock Connect. This inclusion allows eligible domestic investors...

2021-12-06 10:54 2666

OMRON and Doctor Anywhere announce collaboration for digitally enhanced remote hypertension and health management program

* Initiative to strengthen OMRON's vision of 'Going For Zero' (heart attacks and strokes). SINGAPORE, Dec. 6, 2021 /PRNewswire/ -- OMRON Healthcare, the global leader in the field of clinically proven and innovative medical equipment for health monitoring and therapy has announced a strategic ...

2021-12-06 10:46 3394

Henlius' 4th Biologics: Bevacizumab Biosimilar Hanbeitai Approved by National Medical Products Administration

SHANGHAI, Dec. 4, 2021 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that bevacizumab biosimilar Hanbeitai, developed and manufactured by Henlius independently, has been approved by the National Medical Products Administration (NMPA). It is indicated for the treatment of meta...

2021-12-04 01:51 5475

Mongolian Government To Build On COVID-19 Vaccine And Booster Success

* Mongolia secures nearly 70% vaccination rates and an overall casualty rate of only 0.3% * Successes against COVID-19 position country well for ambitious and progressive reforms as part of government's Vision 2050 agenda ULAANBAATAR, Mongolia, Dec. 3, 2021 /PRNewswire/ -- Mongolia is prepari...

2021-12-03 15:00 2086

Elekta's new sustainability-linked bond oversubscribed

STOCKHOLM, Dec. 3, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that it has issuedSEK 1.5 billion senior unsecured sustainability-linked bonds under its Medium Term Note Program (MTN-Program). One of the bonds, in the amount of SEK 1,150 million, has a maturity of 5 years with a coupon ...

2021-12-03 14:54 3127

RemeGen's Telitacicept and Disitamab Vedotin Enter China's National Reimbursement Drug List for SLE and Gastric Cancer Treatment

YANTAI, China, Dec. 3, 2021 /PRNewswire/ -- RemeGen Co., Ltd. (9995.HK), a commercial-ready biotechnology company, today announced that two of its innovative drugs, a dual-targeted TACI-Fc fusion protein, Telitacicept (RC18) for treating systemic lupus erythematosus (SLE) and a novel antibody-dru...

2021-12-03 13:45 3283

Innovent and Lilly Announce Successful Expansion of Sintilimab in China National Reimbursement Drug List to Include Three Additional First-Line Indications

SAN FRANCISCO, INDIANAPOLIS, and SUZHOU, China, Dec. 3, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and ...

2021-12-03 12:37 3445

Ascletis Announces Inclusion in New Catalogue of China National Reimbursement Drug List (NRDL) of ASCLEVIR®/ GANOVO® Regimen, an All-oral Direct Anti-HCV Therapy

HANGZHOU, China and SHAOXING, China, Dec. 3, 2021 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672) today announces that its all-oral direct anti-hepatitis C virus (HCV) ASCLEVIR® (Ravidasvir)/ GANOVO® (Danoprevir) regimen has been included in the Medicine Catalog for National Basic Medical Insu...

2021-12-03 12:05 4179

Decode Genetics Publishes the Largest Ever Study of the Plasma Proteome

REYKJAVIK, Iceland, Dec. 3, 2021 /PRNewswire/ -- In a study published today in Nature genetics, scientists at deCODE genetics , a subsidiary of the pharmaceutical company Amgen, demonstrate how measuring the levels of a large number of proteins in plasma at population scale when combined with dat...

2021-12-03 03:26 2641

Joint CUHK-HKU study discovers efficacy of COVID-19 vaccines correlates with a probiotic bacterium, Bifidobacterium adolescentis

HONG KONG, Dec. 2, 2021 /PRNewswire/ -- The Centre for Gut Microbiota Research of the Faculty of Medicine at TheChinese University of Hong Kong (CU Medicine) is among the first in the world to discover that germs in our gut (gut microbiota) modulate our immunity and disease severity in COVID-19. ...

2021-12-02 21:00 14477

DiNovA Medtech Announces Mr. Yaniv Kirma to Join as DiNovA Israel Incubator's Chief Operating Officer

CAESAREA, Israel, Dec. 2, 2021 /PRNewswire/ -- DiNovA Medtech, a leading medical devices incubator inChina ("DiNovA"), is pleased to announce Mr. Yaniv Kirma, to come on board as Chief Operating Officer of DiNovA Israel Incubator ("DiNovA Israel"). Mr. Kirma will join force with Chief Medical Off...

2021-12-02 16:00 1517

Publication in The New England Journal of Medicine Confirms that Tens of Thousands of Women with Node-positive, Early-stage Breast Cancer Can Avoid Chemotherapy with the Oncotype DX® Test

- RxPONDER, an independent study led by SWOG Cancer Research Network, demonstrates that guiding treatment with Oncotype DX test can spare chemotherapy use in majority of postmenopausal women - Results have already led to updated NCCN Guidelines® for breast cancer - New RxPONDER results to be fea...

2021-12-02 16:00 2480

DoctorOnCall Partners Up With Qualitas Group to Bolster Booster Vaccination Drive

KUALA LUMPUR, Malaysia, Dec. 2, 2021 /PRNewswire/ -- DoctorOnCall, Malaysia's first and largest digital health platform today announced its partnership with Qualitas Medical Group to form a collaborative alliance to extendCOVID-19 vaccination to the population who are yet to receive it, including...

2021-12-02 15:12 2457

P&G Health commemorates Iron Deficiency Day with the launch of the 'First Iron Deficiency Diagnosis and Counselling Guide' for Pharmacists

* Southeast Asia and Africa continue to report the highest prevalence rates of anemia, accounting for 85 percent of global reported cases. * Launched in conjunction with Iron Deficiency Day 2021, the guide with its novel 4-step framework will equip pharmacists with a structured guide to better...

2021-12-02 14:03 2041

CCTV+: Peng Liyuan sends best wishes to students with HIV on World AIDS Day

BEIJING, Dec. 2, 2021 /PRNewswire/ -- On the occasion of the 34th World AIDS Day Wednesday, Peng Liyuan, wife of Chinese President Xi Jinping, sent her best wishes to students in the Linfen Red Ribbon School in northChina's Shanxi Province, the only facility set up in the country specifically for...

2021-12-02 13:58 2135

TOT BIOPHARM Announces NMPA Granted Marketing Approval for Pusintin® (TAB008, Bevacizumab Injection) in China

SUZHOU, China, Dec. 2, 2021 /PRNewswire/ -- TOT BIOPHARM International Company Limited (TOT BIOPHARM, 1875.HK) announced its self-developed Pusintin® (TAB008, bevacizumab injection) has been officially granted approval by the National Medical Products Administration ("NMPA") for marketing in main...

2021-12-02 08:00 2252

SOPHiA GENETICS Announces Launch of DEEP-Lung-IV Multimodal Clinical Study

Study to leverage deep learning-enabled analysis of the aggregation of real-world multimodal data to validate predictive signatures associated with response to immunotherapy and prognosis of patients with stage IV non-small cell lung cancer Large-scale, multicentric real-world study aims to enro...

2021-12-02 02:30 1733

When and How to Screen for Colorectal Cancer? New NCCN Patient Guideline Explains Latest Timing and Approaches

PLYMOUTH MEETING, Pa., Dec. 1, 2021 /PRNewswire/ -- The National Comprehensive Cancer Network (NCCN®) today announced the publication of new NCCN Guidelines for Patients®: Colorectal Cancer Screening. Colorectal cancer (CRC) is the fourth most frequently diagnosed cancer inthe United States, with...

2021-12-01 21:37 1775

VIRALEZE™ antiviral nasal spray registered in Vietnam with launch to follow this week

MELBOURNE, Australia, Dec. 1, 2021 /PRNewswire/ -- Australian biotech company Starpharma  today announced that its broad spectrum antiviral nasal spray, VIRALEZE™, has been registered for sale inVietnam, with the product scheduled to launch inVietnam this week. VIRALEZE™...

2021-12-01 16:40 1669

Dawn Health set out to revolutionize digitalization of the global life science industry with new investment round

COPENHAGEN, Denmark, Dec. 1, 2021 /PRNewswire/ -- Dawn Health, a global leader in digital health, has received aUSD 25 million investment from a consortium of highly experienced investors. The consortium counts Chr. Augustinus Fabrikker, Vaekstfonden - The Danish Growth Fund, and Lars Marcher. Th...

2021-12-01 16:35 1450
1 ... 188189190191192193194 ... 382